April 25, 2022

Eastern Idaho Public Health to Begin Offering Evusheld
This Preventative Antibody Therapy is FDA-EUA Authorized

Eastern Idaho Public Health (EIPH) is pleased to announce that we have started offering Evusheld at all our locations.

Evusheld is an FDA-EUA authorized preventative monoclonal antibody therapy for individuals who are immunocompromised; or individuals who are not effectively protected by the COVID-19 vaccine or unable to receive the COVID-19 vaccine. Patients must also not be currently infected with COVID-19, have not recently been exposed to an infected individual, and meet the additional guidelines provided under the FDA’s Emergency Use Authorization.

Per EIPH standing orders, any individual who has a history of cardiovascular disease and/or who is pregnant, will need an order from their Primary Care Provider to receive Evusheld at our office.

Patients can contact our scheduling line at 208-533-3223 or 855-533-3160 to schedule an appointment starting April 25, 2022.
The following locations will offer Evusheld:

Bonneville County:             Jefferson County:                 Madison County: 
1250 Hollipark Drive          380 Community Lane           314 N 3rd E
Idaho Falls, ID 83401         Rigby, ID 83442                   Rexburg, ID 83440

Fremont County:                 Teton County:                          Clark County:
45 S 2nd W                          820 Valley Centre Dr              332 W Main
St Anthony, ID 83445         Driggs, ID 83422                    Dubois, ID 83423

Custer County:                     Lemhi County:  
610 Clinic Road Ste A         801 Monroe
Challis, ID 83226                 Salmon, ID 83467 

Thank you,
Esmeralda Quintero, BSN RN
Eastern Idaho Public Health
COVID Vaccine Manager
Equintero@eiph.idaho.gov
208-533-3213